1. New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States. Rebeiro PF, Ivey KS, Craig KS, Hulgan T, Huaman MA, Nash R, Raffanti S, Equakun KA, Person AK (2017) J Int Assoc Provid AIDS Care 16(4): 347-352
    › Primary publication · 28560901 (PubMed) · PMC5810363 (PubMed Central)
  2. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR, CHARTER Study Group (2017) Am J Med Genet B Neuropsychiatr Genet 174(4): 413-426
    › Primary publication · 28447399 (PubMed) · PMC5435520 (PubMed Central)
  3. Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care. Kipp AM, Rebeiro PF, Shepherd BE, Brinkley-Rubinstein L, Turner M, Bebawy S, Sterling TR, Hulgan T (2017) AIDS Behav 21(7): 1996-2004
    › Primary publication · 28213820 (PubMed) · PMC5493511 (PubMed Central)
  4. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ, Bush WS, Samuels DC, Franklin DR, Kaur H, Iudicello J, Grant I, Kallianpur AR (2017) Fluids Barriers CNS 14(1): 11
    › Primary publication · 28427421 (PubMed) · PMC5399327 (PubMed Central)
  5. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. Mehta SR, Pérez-Santiago J, Hulgan T, Day TR, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, Suben JD, Franklin D, Rosario D, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur J, McCutchan A, Morgello S, Simpson D, Connor J, Grant I, Kallianpur A (2017) J Neuroinflammation 14(1): 72
    › Primary publication · 28359324 (PubMed) · PMC5374652 (PubMed Central)
  6. Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens. Norwood J, Turner M, Bofill C, Rebeiro P, Shepherd B, Bebawy S, Hulgan T, Raffanti S, Haas DW, Sterling TR, Koethe JR (2017) J Acquir Immune Defic Syndr 76(5): 527-531
    › Primary publication · 28825943 (PubMed) · PMC5680113 (PubMed Central)
  7. Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster. Levinson RT, Hulgan T, Kalams SA, Fessel JP, Samuels DC (2016) Open Forum Infect Dis 3(4): ofw184
    › Primary publication · 27807590 (PubMed) · PMC5088697 (PubMed Central)
  8. European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection. Samuels DC, Kallianpur AR, Ellis RJ, Bush WS, Letendre S, Franklin D, Grant I, Hulgan T (2016) Pathog Immun 1(2): 330-351
    › Primary publication · 28317034 (PubMed) · PMC5351881 (PubMed Central)
  9. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, CHARTER Study Group (2016) J Infect Dis 213(7): 1065-73
    › Primary publication · 26690344 (PubMed) · PMC4779306 (PubMed Central)
  10. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity. Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS (2015) Open Forum Infect Dis 2(2): ofv059
    › Primary publication · 26380350 (PubMed) · PMC4567084 (PubMed Central)